# Effect of the XP1100RF Therapy on Thighs Circumference Reduction

> **NCT02527369** · NA · COMPLETED · sponsor: **BTL Industries Ltd.** · enrollment: 38 (actual)

## Conditions studied

- Thighs Circumferential Reduction
- Subcutaneous Fat Cell Disruption

## Interventions

- **DEVICE:** XP1100RF

## Key facts

- **NCT ID:** NCT02527369
- **Lead sponsor:** BTL Industries Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2020-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02527369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02527369, "Effect of the XP1100RF Therapy on Thighs Circumference Reduction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02527369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*